The early anti-oxidant effect of carvedilol predicts the clinical course in congestive heart failure patients. [electronic resource]
Producer: 20070814Description: 453-6 p. digitalISSN:- 1558-2027
- Adrenergic alpha-Antagonists -- therapeutic use
- Adrenergic beta-Antagonists -- therapeutic use
- Carbazoles -- therapeutic use
- Carvedilol
- Heart Failure -- drug therapy
- Humans
- Myocardial Infarction -- drug therapy
- Propanolamines -- therapeutic use
- Reactive Oxygen Species -- metabolism
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.